Introduction: The subspecialty of paediatric rheumatology (PR) is the newest discipline established at KK Women's and Children's Hospital, in 2009. The service provides tertiary care for children with rheumatic diseases in Singapore. Referral population to this subspecialty has not been described in this region.
INTRODUCTION
Childhood onset rheumatic diseases remain one of the chronic conditions which pose a long-term risk of disability and high mortality if not recognised and treated properly. The dedicated and comprehensive paediatric rheumatology clinical programme was established at KK Women's and Children's Hospital (KKH) in 2009. Since its inception, with the supports of the National Arthritis Foundation of Singapore (NAF) and ILAR (International League of Associations for Rheumatology), the Registry for Childhood Onset Rheumatic Diseases (RECORD), an internet-based registry, was developed. The aim of RECORD is to study the disease epidemiology, efficacy of treatment and outcomes of childhood rheumatic diseases in Singapore and Southeast Asia longitudinally 1 . RECORD also serves as a platform for other observational research to be conducted locally and regionally. Little is known about the epidemiology of paediatric rheumatic diseases in our region. RECORD involves collaboration among the paediatric rheumatologists from Malaysia, Thailand and Philippines. Moreover, there is no data regarding the frequency and burden of the paediatric rheumatology clinic population. This report documents the analysis of KKH rheumatology programme's database, within the duration of 39 months since the programme's establishment and comprising of 1158 paediatric rheumatology clinic referrals.
MATERIALS AND METHODS

Patients
All patients referred to the Paediatric Rheumatology Service at KKH were analysed. The diagnosis for each patient was given according to the published or generally accepted diagnostic or classification criteria 2, 3 . Data pertaining to all patients were prospectively recorded into our web-based registry, RECORD since January 1, 2009. The last patient included in this report was seen on March 31, 2012, giving a 39-month period for this study. Change in diagnosis was allowed if new clinical information occurred; for example, patients presenting with positive ANA were subsequently reclassified as systemic lupus erythematosus (SLE) when criteria for SLE was met.
RESULTS
Characteristics of The Study Population
Of all 1158 patients referred for suspected rheumatic diseases, 1098 (94.8%) were locals and 60 (5.2%) were foreigners (1 Bhutanese, 3 Burmese, 1 Filipino, 1 Sri Lankan, 2 Arab (UAE), 3 Cambodian, 7 Vietnamese and 43 Indonesian). As for locals, the Chinese remain the most commonly encountered race in our study (63.3%), followed by the Malays (14.1%), the Indians (10.9%) and other ethnic backgrounds (11.7%). Gender distribution is almost equal at 569 (49.1%) males and 589 (50.9%) females. The ages at first consultation, ranged from new born to 23.7 years old with a mean of 9.29 + 4.53 years.
Frequencies of Diagnoses in the Clinic Population
Rheumatic diseases were defined as conditions ordinarily cared for by paediatric rheumatologists or conditions for which paediatric rheumatology collaborations or consultations are reasonably requested 2, 3 . Among the 1158 referrals, 669 (57.8%) were rheumatic diseases/conditions, 324 (28.0%) were orthopaedic conditions and 165 (14.2%) were non-rheumatic, non-orthopaedic conditions (Table 1) .
Rheumatic Disease Frequencies
Of all rheumatic diseases, systemic vasculitides, juvenile idiopathic arthritis (JIA), and systemic lupus erythematosus (SLE) and related diseases were among the most common rheumatic diseases evaluated (Table 1) . Enthesitis-related arthritis (ERA), JIA was the most common for which Human * Include neonatal lupus, overlap syndrome, discoid, antiphospholid syndrome ** Include Familial Mediterannean Fever, CINCA, periodic fever, SAPHO *** Include ANA, rheumatoid factor and ANCA positivity + Include autoimmune neurological condition, autoimmune hematological condition, autoimmune hepatitis, autoimmune thyroiditis, uveitis ++ Include chronic recurrent multifocal osteomyelitis, post-infectious myositis, traumatic synovitis, recurrent aphthous ulcer, Kikuchi Disease, Kimura Disease, panniculitis, erythema nodosum (see text) PACNS = primary angiitis of central nervous system, RND = reflex neurovascular dystrophy Leukocyte Antigen B27 (HLA-B27) positive ERA comprised 75% of all ERA patients (Table 2 ). There was no undifferentiated JIA seen in this study. Only 3% of our JIA patients had chronic uveitis and a quarter had positive ANA (25.4%). Overall, male:female ratio was 2:1 for the JIA population. Among SLE-related diseases, SLE, undifferentiated connective tissue disease and mixed connective tissue disease (MCTD) were the top three diseases seen. Henoch-schonlein purpura (HSP) was the most common systemic vasculitis encountered, followed by Kawasaki disease (KD). CNS vasculitis was not uncommon. There was no microscopic polyangiitis (MPA), Wegener's granulomatosis (WG) and polyarteritis nodosa (PAN) referred. Other connective tissue diseases including juvenile dermatomyositis (1.8%), juvenile polymyositis (0.2%), juvenile Sjogren's syndrome (0.3%), localised scleroderma (0.3%) and Pernio (0.2%), were uncommon. Reactive arthritis was commonly seen at 12.1% (81 of 669). Abnormal immunologic laboratory findings (positive ANA, rheumatoid factor or anti-neutrophil cytoplasmic antibody) were found in 36 (5.4%) patients whereas 14 (2.1%) patients had amplified pain syndromes and 6 (0.9%) patients had auto-inflammatory syndromes which included one patient with familial mediterranean fever (FMF), one patient with SAPHO (Synovitis, Acne, Pustolosis, Hyperostosis & Osteitis) syndrome, two patients with CINCA (Chronic Infantile Neurological, Cutaneous and Articular) syndrome and two patients with undifferentiated periodic fever syndrome. 28 (4.2%) patients had autoimmune organ involvement which composed of eight (1.2%) patients with inflammatory bowel disease (IBD), nine (1.4%) patients with uveitis, three (0.4%) patients with autoimmune thyroid disease and the remaining eight patients (1.2%) with other organ involvement. Miscellaneous rheumatic diseases/conditions were malignancyassociated arthritis (1.5%), Kikuchi disease (1.6%), Kimura disease (0.3%), chronic recurrent multifocal osteomyelitis (CRMO, 0.4%), post-infectious myositis (1.5%), recurrent aphthous stomatitis (2.6%), panniculitis (0.3%), post-streptococcual reactive arthritis (1.5%), traumatic synovitis (1.5%) and erythema nodosum (0.6%).
Miscellaneous (Occuring in 1 patient)
Non-Rheumatic Disease Frequencies
Orthopaedic conditions were the most common non-rheumatic diseases seen (66.3%), of which, mechanical joint pain remained the most common encounter, whereas hypermobility joint disease was the second most common at 12.3%. Growing pain was diagnosed only in 2.5% of patients. Fever of unknown causes and infectious conditions were Prior to this, there is no report describing the paediatric rheumatology clinic population, thus the frequencies or burden of the diseases cannot be estimated. Recognising the paediatric rheumatology clinic population helped to describe the spectrum of diseases evaluated and offered comparison with others. With differences in disease spectrums and frequencies, heightening specific local diseases' awareness, planning of healthcare budget and guiding of research study can be effectively targeted. KKH paediatric rheumatology programme evaluated about 88% of all Singapore paediatric rheumatology referrals, therefore the data reported here will be reflective of the local disease frequencies.
Our study was in accordance with other previous reports that noted high rates of children with nonrheumatic conditions being referred to paediatric rheumatology clinics, except for India 2, [4] [5] [6] [7] . A total of 42.2% of our referrals were for non-rheumatic diseases, which was comparable to the study by Hashkes et al 5 , which reported 39% of nonrheumatic diseases referred to their clinics. This is slightly less than what was previously reported in other studies (Table 3) . This is likely to reflect the accessibility of patients to healthcare providers. In developing countries, unlike adults, children with non-severe conditions or children with parents of low income/education may be overlooked by care givers leading to inadequate awareness of certain disability-prone illnesses. Only children with significantly severe diseases will be referred to the proper healthcare providers. A lack of paediatric rheumatologists is another well-known problem in paediatric rheumatic disease care in some countries 1 . Additionally, there have been several unique findings that are worth mentioning. Firstly, systemic vasculitides were the most common rheumatic diseases encountered in Singapore, instead of JIA which was the most common in other countries (Table 3 ). Our study found that the two most common vasculitides were HSP (56%) and KD (28%) as has been reported by others 2, 4 . Half of our HSP patients were admitted for acute abdominal pain and/or inability to ambulate. However, this was not seen in patients from western countries 8 . Most of the KD cases being referred to our service were either atypical or intravenous immunoglobulin (IVIG) resistant KD. Other childhood onset medium and small vessel vasculitides were not common in our patients. One possibility is that certain vasculitides (WG, Churg Strauss syndrome and PAN) occur more commonly in older individuals who are more likely to frequent adult rheumatologists.
Secondly, the distribution of JIA was different ( Table 2 ). The ERA subtype was most frequently seen with HLA-B27 positivity in three-quarters of our patients. Chinese patients made up the majority at 82%. Systemic onset JIA (SoJIA) remains one of the rheumatic diseases that results in high morbidity and mortality if left untreated 9 . The frequency of SoJIA in our study can be further compounded by studies from Taiwan (8%), United States (10%), Canada (11%) and South India (13%). However, other studies from Thailand (60%), Japan (54%), Kuwait (29%), North India (24%), and Israel (18%) were contradictory to our report 2, 5, [10] [11] [12] [13] [14] [15] [16] . Onethird of our patients suffering from JIA were of the oligoarticular subtype while polyarticular JIA was the least common. This is in accordance with other reports [17] [18] [19] .
Thirdly, we saw more male than female patients in our JIA cohort, which was not observed in other countries [17] [18] [19] [20] [21] . This is likely due in part to our prominent HLA-B27 positive ERA subtype existence.
Fourthly, low prevalence of JIA associated uveitis observed in our cohort (3%) was comparable to that reported in Turkey. This observation is parallel with the frequencies of ANA positivity in both cohorts (Singapore and Turkey) at 25% and 14%, respectively. This finding suggests that the influence of ANA positivity to the risk of uveitis development remains true in our region.
Fifthly, psoriatic arthritis was uncommon in Singapore, as compared to that in the United Kingdom (UK) and Germany 17, 18 .
Sixthly, certain rheumatic diseases' frequencies were unique: amplified pain syndrome, Sjogren's syndrome and systemic sclerosis were infrequent. Recurrent aphthous stomatitis (RAS) and primary angiitis of the CNS were diagnosed more frequently and their significance is not known at this moment.
Seventhly, 6.2% of our clinic population had SLE, which was comparable to that reported in India (7%), USA (9.1%) and Austria (6.5%) as seen in Table  2 . In Singapore, Arkachaisri reported that the point prevalence for SLE was at least 14.2 per 100,000 patients 1 . SLE was more common in Thailand and Malaysia (15-20%, unpublished data). This was in accordance to the reported prevalence of adult and paediatric SLE, which was higher among Asians, as compared with Caucasians 11, 22, 23 .
Biologics Used
The availability of biologics is not an issue in Singapore. However, the cost of biologics remains a limiting factor despite Singapore being one of the countries in the world with the highest gross domestic product (GDP), per capita of US$ 49,271/year in 2011. As of June 30, 2012, a total of 82 patients in Singapore are on biologics (53-etanercept, 21-adalimumab, 3-infliximab, 5-tocilizumab), which consisted of 38.9% of the total patients with diagnosed JIA.
Over the years, the number of diagnosis for paediatric rheumatic diseases has been increasing in Singapore; this is the result of increased awareness along with the number of paediatric rheumatologist available. The dedicated programme at KKH has grown substantially (both in the number of subspecialists from one to three and increased referrals) with our latest addition to the programme including the musculoskeletal ultrasound offering improvement in diagnostic and therapeutic accuracy and outcomes. Continuous public education and training for general practitioners, undergraduates and postgraduates about rheumatic/musculoskeletal diseases have all contributed to an increase in awareness in the public and medical communities.
The limitation in our study is the nature of a single centre experience. As mentioned above, KKH is the
